Amprius Technologies (AMPX) Financials

$7.11 +0.32 (+4.70%)

As of 10:26 AM Eastern

Annual Income Statements for Amprius Technologies

This table shows Amprius Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-9.90	-17	-37	-45
Consolidated Net Income / (Loss)	-9.90	-17	-37	-45
Net Income / (Loss) Continuing Operations	-9.90	-17	-37	-45
Total Pre-Tax Income	-9.90	-17	-37	-45
Total Operating Income	-11	-18	-39	-46
Total Gross Profit	-4.33	-5.65	-15	-18
Total Revenue	2.77	4.41	9.05	24
Operating Revenue	2.77	4.41	9.05	24
Total Cost of Revenue	7.10	10	24	42
Operating Cost of Revenue	7.10	10	24	42
Total Operating Expenses	6.29	12	24	28
Selling, General & Admin Expense	4.84	10	20	19
Research & Development Expense	1.45	2.03	3.68	7.34
Other Special Charges / (Income)	-	-	0.00	1.86
Total Other Income / (Expense), net	0.73	0.71	1.93	1.59
Interest & Investment Income	-0.02	0.71	2.51	1.59
Other Income / (Expense), net	-	-	-0.58	0.00
Basic Earnings per Share	($0.15)	($0.24)	($0.43)	($0.45)
Weighted Average Basic Shares Outstanding	65.76M	71.34M	86.20M	101.87M
Diluted Earnings per Share	($0.15)	($0.24)	($0.43)	($0.45)
Weighted Average Diluted Shares Outstanding	65.76M	71.34M	86.20M	101.87M
Weighted Average Basic & Diluted Shares Outstanding	-	84.63M	91.60M	117.93M

This table shows Amprius Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-4.24	-6.06	-9.10	-9.45	-8.49	-9.73	-9.89	-13	-11	-11	-9.37
Consolidated Net Income / (Loss)	-4.24	-6.06	-9.10	-9.45	-8.49	-9.73	-9.89	-13	-11	-11	-9.37
Net Income / (Loss) Continuing Operations	-4.24	-6.06	-9.10	-9.45	-8.49	-9.73	-9.89	-13	-11	-11	-9.37
Total Pre-Tax Income	-4.24	-6.06	-9.10	-9.45	-8.49	-9.73	-9.89	-13	-11	-11	-9.37
Total Operating Income	-4.32	-6.65	-9.75	-10	-9.13	-9.74	-10	-13	-11	-12	-9.67
Total Gross Profit	-1.51	-1.74	-3.52	-3.03	-4.25	-3.88	-4.45	-6.53	-5.10	-2.25	-2.36
Total Revenue	0.82	0.79	0.68	1.63	2.80	3.94	2.34	3.35	7.86	11	11
Operating Revenue	0.82	0.79	0.68	1.63	2.80	3.94	2.34	3.35	7.86	11	11
Total Cost of Revenue	2.33	2.53	4.20	4.66	7.05	7.82	6.78	9.88	13	13	14
Operating Cost of Revenue	2.33	2.53	4.20	4.66	7.05	7.82	6.78	9.88	13	13	14
Total Operating Expenses	2.81	4.91	6.23	7.05	4.88	5.87	5.87	6.40	6.15	9.51	7.31
Selling, General & Admin Expense	2.32	4.22	5.43	6.28	4.07	4.58	4.29	4.74	4.34	5.36	5.31
Research & Development Expense	0.49	0.69	0.80	0.77	0.82	1.29	1.58	1.66	1.82	2.28	2.00
Total Other Income / (Expense), net	0.08	0.59	0.65	0.64	0.64	0.01	0.43	0.42	0.40	0.34	0.30
Basic Earnings per Share	($0.06)	($0.08)	($0.11)	($0.11)	($0.10)	($0.11)	($0.11)	($0.13)	($0.10)	($0.11)	($0.08)
Weighted Average Basic Shares Outstanding	69.01M	71.34M	84.65M	85.22M	86.35M	86.20M	90.03M	97.05M	110.41M	101.87M	117.97M
Diluted Earnings per Share	($0.06)	($0.08)	($0.11)	($0.11)	($0.10)	($0.11)	($0.11)	($0.13)	($0.10)	($0.11)	($0.08)
Weighted Average Diluted Shares Outstanding	69.01M	71.34M	84.65M	85.22M	86.35M	86.20M	90.03M	97.05M	110.41M	101.87M	117.97M
Weighted Average Basic & Diluted Shares Outstanding	84.47M	84.63M	84.97M	86.27M	88.40M	91.60M	94.47M	111.05M	105.84M	117.93M	120.55M

This table details how cash moves in and out of Amprius Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	11	58	-24	11
Net Cash From Operating Activities	-8.02	-14	-26	-33
Net Cash From Continuing Operating Activities	-8.02	-14	-26	-33
Net Income / (Loss) Continuing Operations	-9.90	-17	-37	-45
Consolidated Net Income / (Loss)	-9.90	-17	-37	-45
Depreciation Expense	1.44	1.54	1.81	3.81
Amortization Expense	0.55	1.59	3.06	6.39
Non-Cash Adjustments To Reconcile Net Income	1.89	3.27	5.61	9.21
Changes in Operating Assets and Liabilities, net	-2.00	-2.94	0.75	-8.08
Net Cash From Investing Activities	-0.61	-1.48	-18	-3.21
Net Cash From Continuing Investing Activities	-0.61	-1.48	-18	-3.21
Purchase of Property, Plant & Equipment	-0.61	-1.48	-18	-3.21
Net Cash From Financing Activities	20	74	19	47
Net Cash From Continuing Financing Activities	20	74	19	47
Repurchase of Common Equity	0.00	-0.33	-0.60	-0.76
Issuance of Common Equity	0.00	78	19	33
Other Financing Activities, net	20	-3.93	0.31	14

This table details how cash moves in and out of Amprius Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	69	-4.38	-5.51	0.82	-12	-7.64	-5.52	7.40	-11	20	-6.53
Net Cash From Operating Activities	-2.69	-5.70	-6.49	-5.58	-8.68	-4.80	-9.78	-7.96	-9.53	-6.09	-14
Net Cash From Continuing Operating Activities	-2.69	-5.70	-6.49	-5.58	-8.68	-4.80	-9.78	-7.96	-9.53	-6.09	-14
Net Income / (Loss) Continuing Operations	-4.24	-6.06	-9.10	-9.45	-8.49	-9.73	-9.89	-13	-11	-11	-9.37
Consolidated Net Income / (Loss)	-4.24	-6.06	-9.10	-9.45	-8.49	-9.73	-9.89	-13	-11	-11	-9.37
Depreciation Expense	0.39	0.40	0.42	0.44	0.46	0.49	1.02	1.04	0.86	0.89	0.94
Amortization Expense	0.33	-	0.34	0.07	1.48	1.18	1.29	-	5.10	1.29	1.29
Non-Cash Adjustments To Reconcile Net Income	0.91	0.73	0.73	1.43	0.61	2.84	1.25	3.23	-0.85	4.30	2.10
Changes in Operating Assets and Liabilities, net	-0.09	-0.77	1.13	1.93	-2.74	0.43	-3.44	0.30	-3.80	-1.14	-9.08
Net Cash From Investing Activities	-0.55	-0.73	-1.14	-1.73	-8.93	-5.75	-3.90	-1.61	-1.33	3.63	-0.91
Net Cash From Continuing Investing Activities	-0.55	-0.73	-1.14	-1.73	-8.93	-5.75	-3.90	-1.61	-1.33	3.63	-0.91
Purchase of Property, Plant & Equipment	-0.55	-0.73	-1.14	-1.73	-8.93	-5.75	-3.90	-1.61	-1.33	3.63	-0.91
Net Cash From Financing Activities	72	2.05	2.12	8.13	6.00	2.92	8.16	17	-0.54	23	8.51
Net Cash From Continuing Financing Activities	72	2.05	2.12	8.13	6.00	2.92	8.16	17	-0.54	23	8.51
Issuance of Common Equity	78	-	2.39	8.12	6.04	2.92	8.13	2.73	-	23	8.46
Other Financing Activities, net	-6.05	2.35	0.00	0.00	0.11	0.20	0.03	14	-	0.01	0.05
Effect of Exchange Rate Changes	-	-	-	-	-	-	0.00	-	-	-	-0.00

This table presents Amprius Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	19	83	108	121
Total Current Assets	14	75	51	69
Cash & Equivalents	11	70	46	55
Accounts Receivable	0.26	0.69	1.27	5.58
Inventories, net	0.50	0.50	0.73	6.57
Prepaid Expenses	0.16	2.39	1.99	1.45
Plant, Property, & Equipment, net	4.21	4.24	22	17
Total Noncurrent Assets	0.14	3.76	35	35
Other Noncurrent Operating Assets	0.14	3.76	35	35
Total Liabilities & Shareholders' Equity	19	83	108	121
Total Liabilities	4.67	10	48	52
Total Current Liabilities	4.17	6.92	13	17
Accounts Payable	1.81	3.74	8.94	12
Current Deferred Revenue	2.36	2.66	3.43	1.64
Other Current Liabilities	0.00	0.52	1.09	3.32
Total Noncurrent Liabilities	0.50	3.22	34	34
Other Noncurrent Operating Liabilities	0.00	2.50	34	34
Commitments & Contingencies	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	14	73	60	69
Total Preferred & Common Equity	14	73	60	69
Preferred Stock	-	0.00	0.00	0.00
Total Common Equity	14	73	60	69
Common Stock	89	166	189	244
Retained Earnings	-75	-93	-130	-174
Accumulated Other Comprehensive Income / (Loss)	-	-	-	0.00

This table presents Amprius Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	87	84	87	87	105	113	104	118
Total Current Assets	78	70	71	61	46	53	45	66
Cash & Equivalents	74	64	65	53	39	46	35	48
Accounts Receivable	0.78	0.56	1.13	1.89	1.44	1.74	4.59	10
Inventories, net	0.50	0.85	0.50	0.49	0.86	1.53	2.66	4.00
Prepaid Expenses	2.32	1.84	1.48	2.74	3.35	2.17	2.64	3.31
Plant, Property, & Equipment, net	3.82	4.95	6.90	17	23	24	24	18
Total Noncurrent Assets	4.86	9.10	9.03	8.55	36	36	35	34
Other Noncurrent Operating Assets	4.86	9.10	9.03	8.55	36	36	35	34
Total Liabilities & Shareholders' Equity	87	84	87	87	105	113	104	118
Total Liabilities	11	17	20	21	45	48	48	48
Total Current Liabilities	6.14	8.88	12	14	9.76	13	13	14
Accounts Payable	4.82	4.69	7.74	9.23	5.42	7.76	9.13	8.55
Current Deferred Revenue	0.80	3.14	3.20	3.57	3.24	3.15	1.82	1.78
Other Current Liabilities	0.52	1.06	1.07	1.08	1.10	1.92	2.05	3.64
Total Noncurrent Liabilities	4.36	8.03	7.94	6.98	35	35	35	34
Other Noncurrent Operating Liabilities	2.58	7.13	7.00	6.87	35	35	35	34
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	76	67	67	66	60	65	56	70
Total Preferred & Common Equity	76	67	67	66	60	65	56	70
Preferred Stock	-	-	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	76	67	67	66	60	65	56	70
Common Stock	163	169	178	186	199	217	219	254
Retained Earnings	-87	-102	-111	-120	-140	-152	-163	-184
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-	-	-	-	-0.00

This table displays calculated financial ratios and metrics derived from Amprius Technologies' official financial filings.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	59.05%	105.33%	166.95%
EBITDA Growth	0.00%	-72.77%	-130.79%	-4.76%
EBIT Growth	0.00%	-69.83%	-117.78%	-17.75%
NOPAT Growth	0.00%	-69.83%	-114.56%	-19.51%
Net Income Growth	0.00%	-75.14%	-112.19%	-21.47%
EPS Growth	0.00%	-60.00%	-79.17%	-4.65%
Operating Cash Flow Growth	0.00%	-73.18%	-84.07%	-30.52%
Free Cash Flow Firm Growth	0.00%	0.00%	-178.00%	13.59%
Invested Capital Growth	0.00%	40.86%	320.71%	1.98%
Revenue Q/Q Growth	0.00%	0.00%	53.41%	38.26%
EBITDA Q/Q Growth	0.00%	0.00%	-7.54%	-4.34%
EBIT Q/Q Growth	0.00%	0.00%	-10.33%	-4.55%
NOPAT Q/Q Growth	0.00%	0.00%	-8.70%	-4.55%
Net Income Q/Q Growth	0.00%	0.00%	-11.11%	-3.92%
EPS Q/Q Growth	0.00%	0.00%	-7.50%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	-40.32%	3.40%	-4.01%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	17.45%
Invested Capital Q/Q Growth	0.00%	0.00%	13.58%	-31.67%
Profitability Metrics	-	-	-	-
Gross Margin	-156.17%	-128.24%	-162.11%	-75.85%
EBITDA Margin	-311.47%	-338.33%	-380.28%	-149.23%
Operating Margin	-383.23%	-409.19%	-427.58%	-191.43%
EBIT Margin	-383.23%	-409.19%	-434.00%	-191.43%
Profit (Net Income) Margin	-357.00%	-393.11%	-406.23%	-184.84%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	93.16%	96.07%	93.60%	96.56%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-313.89%	-442.65%	-311.88%	-228.41%
ROIC Less NNEP Spread (ROIC-NNEP)	-292.48%	-431.06%	-295.11%	-204.05%
Return on Net Nonoperating Assets (RNNOA)	242.48%	402.75%	256.51%	159.29%
Return on Equity (ROE)	-71.41%	-39.89%	-55.37%	-69.11%
Cash Return on Invested Capital (CROIC)	0.00%	-476.58%	-435.06%	-230.37%
Operating Return on Assets (OROA)	-57.34%	-35.48%	-41.16%	-40.43%
Return on Assets (ROA)	-53.41%	-34.09%	-38.53%	-39.04%
Return on Common Equity (ROCE)	-71.41%	-39.89%	-55.37%	-69.11%
Return on Equity Simple (ROE_SIMPLE)	-71.41%	-23.73%	-61.50%	-64.30%
Net Operating Profit after Tax (NOPAT)	-7.44	-13	-27	-32
NOPAT Margin	-268.26%	-286.43%	-299.31%	-134.00%
Net Nonoperating Expense Percent (NNEP)	-21.41%	-11.59%	-16.77%	-24.35%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-45.31%	-46.61%
Cost of Revenue to Revenue	256.17%	228.24%	262.11%	175.85%
SG&A Expenses to Revenue	174.75%	234.97%	224.85%	77.49%
R&D to Revenue	52.31%	45.97%	40.62%	30.39%
Operating Expenses to Revenue	227.06%	280.95%	265.47%	115.58%
Earnings before Interest and Taxes (EBIT)	-11	-18	-39	-46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-8.63	-15	-34	-36
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	14.43	9.17	7.82	4.27
Price to Tangible Book Value (P/TBV)	14.43	9.17	7.82	4.27
Price to Revenue (P/Rev)	72.15	151.92	51.65	12.26
Price to Earnings (P/E)	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	79.57	179.84	30.05	16.85
Enterprise Value to Revenue (EV/Rev)	68.01	136.12	46.60	9.98
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00
Financial Leverage	-0.83	-0.93	-0.87	-0.78
Leverage Ratio	1.34	1.17	1.44	1.77
Compound Leverage Factor	1.25	1.12	1.35	1.71
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00
Altman Z-Score	18.91	38.40	3.46	0.88
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-
Current Ratio	3.40	10.87	3.75	4.00
Quick Ratio	2.82	10.18	3.49	3.53
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-14	-38	-33
Operating Cash Flow to CapEx	-1,316.26%	-937.34%	-145.60%	-1,039.98%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-
Asset Turnover	0.15	0.09	0.09	0.21
Accounts Receivable Turnover	10.58	9.30	9.28	7.06
Inventory Turnover	14.20	20.13	38.58	11.64
Fixed Asset Turnover	0.66	1.04	0.70	1.23
Accounts Payable Turnover	3.93	3.63	3.75	4.01
Days Sales Outstanding (DSO)	34.50	39.24	39.33	51.69
Days Inventory Outstanding (DIO)	25.70	18.14	9.46	31.37
Days Payable Outstanding (DPO)	92.78	100.49	97.45	91.00
Cash Conversion Cycle (CCC)	-32.58	-43.11	-48.66	-7.95
Capital & Investment Metrics	-	-	-	-
Invested Capital	2.37	3.34	14	14
Invested Capital Turnover	1.17	1.55	1.04	1.70
Increase / (Decrease) in Invested Capital	0.00	0.97	11	0.28
Enterprise Value (EV)	189	600	422	241
Market Capitalization	200	670	468	296
Book Value per Share	$0.21	$0.86	$0.68	$0.66
Tangible Book Value per Share	$0.21	$0.86	$0.68	$0.66
Total Capital	14	73	60	69
Total Debt	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00
Net Debt	-11	-70	-46	-55
Capital Expenditures (CapEx)	0.61	1.48	18	3.21
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1.48	-1.44	-8.70	-3.60
Debt-free Net Working Capital (DFNWC)	10	68	37	52
Net Working Capital (NWC)	10	68	37	52
Net Nonoperating Expense (NNE)	2.46	4.70	9.68	12
Net Nonoperating Obligations (NNO)	-11	-70	-46	-55
Total Depreciation and Amortization (D&A)	1.99	3.12	4.86	10
Debt-free, Cash-free Net Working Capital to Revenue	-53.43%	-32.66%	-96.06%	-14.90%
Debt-free Net Working Capital to Revenue	361.04%	1,548.11%	409.42%	213.32%
Net Working Capital to Revenue	361.04%	1,548.11%	409.42%	213.32%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($0.24)	($0.43)	($0.45)
Adjusted Weighted Average Basic Shares Outstanding	0.00	71.34M	86.20M	101.87M
Adjusted Diluted Earnings per Share	$0.00	($0.24)	($0.43)	($0.45)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	71.34M	86.20M	101.87M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	84.63M	91.60M	117.93M
Normalized Net Operating Profit after Tax (NOPAT)	-7.44	-13	-27	-31
Normalized NOPAT Margin	-268.26%	-286.43%	-299.31%	-128.61%
Pre Tax Income Margin	-357.00%	-393.11%	-406.23%	-184.84%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-1.88%	-1.63%	-1.69%

This table displays calculated financial ratios and metrics derived from Amprius Technologies' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	147.27%	0.00%	-67.82%	136.18%	242.89%	397.98%	244.04%	104.96%	180.74%	169.55%	383.05%
EBITDA Growth	-14.70%	0.00%	-592.23%	-153.96%	-99.83%	-29.32%	-3.37%	-24.21%	26.48%	-18.58%	7.16%
EBIT Growth	-37.81%	0.00%	-235.09%	-142.32%	-111.22%	-46.59%	-5.83%	-28.26%	-23.24%	-20.67%	6.28%
NOPAT Growth	-37.81%	0.00%	-235.09%	-142.32%	-111.22%	-46.59%	-5.83%	-28.26%	-23.24%	-20.67%	6.28%
Net Income Growth	-35.12%	0.00%	-216.26%	-127.44%	-100.09%	-60.73%	-8.61%	-32.48%	-27.77%	-17.30%	5.21%
EPS Growth	-20.00%	0.00%	-175.00%	-83.33%	-66.67%	-37.50%	0.00%	-18.18%	0.00%	0.00%	27.27%
Operating Cash Flow Growth	0.00%	-233.41%	-113.34%	-127.97%	-222.36%	15.76%	-50.63%	-42.56%	-9.81%	-26.77%	-44.45%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	-216.79%	0.00%	-112.85%	-112.94%	0.49%	51.44%	68.90%
Invested Capital Growth	0.00%	0.00%	-98.62%	-99.20%	462.07%	320.71%	633.50%	1,012.02%	69.53%	1.98%	5.21%
Revenue Q/Q Growth	18.09%	-2.94%	-14.27%	140.35%	71.45%	40.96%	-40.77%	43.19%	134.83%	35.34%	6.14%
EBITDA Q/Q Growth	4.59%	-73.65%	-44.03%	-6.42%	24.92%	-12.38%	-27.97%	-27.89%	55.56%	-81.25%	22.33%
EBIT Q/Q Growth	-3.89%	-53.76%	-46.70%	-3.40%	9.44%	-6.71%	-5.90%	-25.32%	12.98%	-4.49%	17.75%
NOPAT Q/Q Growth	-3.89%	-53.76%	-46.70%	-3.40%	9.44%	-6.71%	-5.90%	-25.32%	12.98%	-4.49%	17.75%
Net Income Q/Q Growth	-2.17%	-42.70%	-50.30%	-3.80%	10.12%	-14.63%	-1.56%	-26.61%	13.32%	-5.24%	17.93%
EPS Q/Q Growth	0.00%	-33.33%	-37.50%	0.00%	9.09%	-10.00%	0.00%	-18.18%	23.08%	-10.00%	27.27%
Operating Cash Flow Q/Q Growth	-9.92%	-111.66%	-13.93%	14.00%	-55.44%	44.69%	-103.73%	18.61%	-19.73%	36.14%	-132.14%
Free Cash Flow Firm Q/Q Growth	0.00%	100.00%	0.00%	2.39%	-108.22%	-5.86%	-44.19%	-3.12%	36.78%	48.34%	7.64%
Invested Capital Q/Q Growth	-98.95%	51.75%	-14.65%	-41.01%	635.71%	13.58%	48.80%	-10.57%	12.16%	-31.67%	53.52%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	-185.05%	-219.82%	-517.97%	-185.78%	-151.82%	-98.35%	-190.28%	-195.25%	-64.94%	-21.19%	-20.92%
EBITDA Margin	-440.93%	-788.89%	-1,325.33%	-586.83%	-256.97%	-204.87%	-398.20%	-355.64%	-67.29%	-90.12%	-65.95%
Operating Margin	-529.78%	-839.27%	-1,436.08%	-617.83%	-326.34%	-247.06%	-441.74%	-386.61%	-143.26%	-110.60%	-85.71%
EBIT Margin	-529.78%	-839.27%	-1,436.08%	-617.83%	-326.34%	-247.06%	-441.74%	-386.61%	-143.26%	-110.60%	-85.71%
Profit (Net Income) Margin	-520.10%	-764.65%	-1,340.50%	-578.92%	-303.50%	-246.81%	-423.20%	-374.20%	-138.13%	-107.40%	-83.05%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	98.17%	91.11%	93.34%	93.70%	93.00%	99.90%	95.80%	96.79%	96.42%	97.11%	96.90%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-776.22%	-28.63%	-16.01%	-185.18%	-180.21%	-279.02%	-330.22%	-105.24%	-131.97%	-92.69%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-774.20%	-21.81%	-8.85%	-181.88%	-175.16%	-273.86%	-324.00%	-98.51%	-125.65%	-86.74%
Return on Net Nonoperating Assets (RNNOA)	0.00%	738.83%	5.28%	2.12%	163.20%	152.25%	222.66%	273.95%	71.56%	98.09%	58.21%
Return on Equity (ROE)	0.00%	-37.39%	-23.34%	-13.89%	-21.98%	-27.96%	-56.36%	-56.27%	-33.68%	-33.88%	-34.48%
Cash Return on Invested Capital (CROIC)	0.00%	-407.45%	0.00%	0.00%	0.00%	-435.06%	-383.65%	-456.64%	-237.54%	-230.37%	-154.05%
Operating Return on Assets (OROA)	0.00%	-72.77%	-26.98%	-15.17%	-22.25%	-23.43%	-50.16%	-48.17%	-26.25%	-23.36%	-25.44%
Return on Assets (ROA)	0.00%	-66.30%	-25.19%	-14.21%	-20.69%	-23.41%	-48.06%	-46.63%	-25.31%	-22.68%	-24.65%
Return on Common Equity (ROCE)	0.00%	-37.39%	-3.89%	-2.41%	-21.98%	-27.96%	-56.36%	-56.27%	-33.68%	-33.88%	-34.48%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	-35.14%	-43.26%	-50.33%	0.00%	-62.67%	-62.38%	-76.76%	0.00%	-62.73%
Net Operating Profit after Tax (NOPAT)	-3.03	-4.65	-6.83	-7.06	-6.39	-6.82	-7.22	-9.05	-7.88	-8.23	-6.77
NOPAT Margin	-370.85%	-587.49%	-1,005.26%	-432.48%	-228.44%	-172.94%	-309.22%	-270.62%	-100.28%	-77.42%	-59.99%
Net Nonoperating Expense Percent (NNEP)	-3.30%	-2.01%	-6.81%	-7.16%	-3.30%	-5.05%	-5.16%	-6.22%	-6.72%	-6.32%	-5.95%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-11.41%	-	-	-	-11.85%	-9.62%
Cost of Revenue to Revenue	285.05%	319.82%	617.97%	285.78%	251.82%	198.35%	290.28%	295.25%	164.94%	121.19%	120.92%
SG&A Expenses to Revenue	284.68%	532.32%	800.29%	384.74%	145.39%	116.00%	183.78%	141.67%	55.19%	50.41%	47.03%
R&D to Revenue	60.05%	87.12%	117.82%	47.30%	29.13%	32.71%	67.68%	49.69%	23.13%	21.48%	17.75%
Operating Expenses to Revenue	344.73%	619.44%	918.11%	432.05%	174.52%	148.71%	251.46%	191.36%	78.32%	89.41%	64.78%
Earnings before Interest and Taxes (EBIT)	-4.32	-6.65	-9.75	-10	-9.13	-9.74	-10	-13	-11	-12	-9.67
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-3.60	-6.25	-9.00	-9.58	-7.19	-8.08	-9.30	-12	-5.29	-9.58	-7.44
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.99	9.17	11.00	9.15	6.22	7.82	4.05	1.84	2.20	4.27	4.49
Price to Tangible Book Value (P/TBV)	3.99	9.17	11.00	9.15	6.22	7.82	4.05	1.84	2.20	4.27	4.49
Price to Revenue (P/Rev)	0.00	151.92	247.52	155.68	69.30	51.65	22.66	9.66	7.05	12.26	9.54
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	104.26	179.84	236.29	324.46	28.77	30.05	9.75	3.94	4.21	16.85	12.18
Enterprise Value to Revenue (EV/Rev)	0.00	136.12	225.97	139.09	60.25	46.60	19.02	5.92	5.05	9.98	8.08
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.97	-0.95	-0.24	-0.24	-0.90	-0.87	-0.81	-0.85	-0.73	-0.78	-0.67
Leverage Ratio	1.14	1.17	1.15	1.15	1.22	1.44	1.49	1.51	1.57	1.77	1.71
Compound Leverage Factor	1.12	1.07	1.07	1.07	1.14	1.44	1.42	1.46	1.51	1.72	1.66
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	38.85	24.97	17.02	10.20	4.37	1.58	-0.22	-0.48	1.82	2.31
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	83.33%	82.64%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	12.68	10.87	7.87	5.89	4.42	3.75	4.67	4.14	3.46	4.00	4.74
Quick Ratio	12.16	10.18	7.29	5.51	3.98	3.49	4.15	3.76	3.05	3.53	4.21
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-5.23	0.00	197	201	-17	-18	-25	-26	-16	-8.51	-7.86
Operating Cash Flow to CapEx	-486.80%	-776.29%	-569.47%	-323.09%	-97.17%	-83.46%	-251.00%	-495.89%	-714.85%	0.00%	-1,547.21%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.09	0.02	0.02	0.07	0.09	0.11	0.12	0.18	0.21	0.30
Accounts Receivable Turnover	0.00	9.30	0.00	0.00	4.42	9.28	10.73	8.66	5.40	7.06	5.59
Inventory Turnover	0.00	20.13	0.00	0.00	37.25	38.58	30.90	31.06	23.76	11.64	20.31
Fixed Asset Turnover	0.00	1.04	0.00	0.00	0.58	0.70	0.77	0.81	0.86	1.23	1.62
Accounts Payable Turnover	0.00	3.63	4.67	3.53	2.62	3.75	5.21	4.07	4.08	4.01	7.07
Days Sales Outstanding (DSO)	0.00	39.24	0.00	0.00	82.54	39.33	34.03	42.13	67.62	51.69	65.24
Days Inventory Outstanding (DIO)	0.00	18.14	0.00	0.00	9.80	9.46	11.81	11.75	15.36	31.37	17.97
Days Payable Outstanding (DPO)	0.00	100.49	78.18	103.33	139.07	97.45	70.12	89.71	89.49	91.00	51.65
Cash Conversion Cycle (CCC)	0.00	-43.11	-78.18	-103.33	-46.73	-48.66	-24.28	-35.83	-6.51	-7.95	31.57
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2.20	3.34	2.85	1.68	12	14	21	19	21	14	22
Invested Capital Turnover	0.00	1.32	0.03	0.04	0.81	1.04	0.90	1.22	1.05	1.70	1.54
Increase / (Decrease) in Invested Capital	2.20	0.00	-203	-208	10	11	18	17	8.59	0.28	1.09
Enterprise Value (EV)	229	600	673	545	356	422	204	74	88	241	268
Market Capitalization	303	670	737	610	409	468	243	120	123	296	316
Book Value per Share	$2.31	$0.86	$0.79	$0.78	$0.76	$0.68	$0.65	$0.69	$0.50	$0.66	$0.60
Tangible Book Value per Share	$2.31	$0.86	$0.79	$0.78	$0.76	$0.68	$0.65	$0.69	$0.50	$0.66	$0.60
Total Capital	76	73	67	67	66	60	60	65	56	69	70
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-74	-70	-64	-65	-53	-46	-39	-46	-35	-55	-48
Capital Expenditures (CapEx)	0.55	0.73	1.14	1.73	8.93	5.75	3.90	1.61	1.33	-3.63	0.91
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-2.12	-1.44	-3.17	-6.32	-5.88	-8.70	-3.18	-6.23	-3.11	-3.60	3.75
Debt-free Net Working Capital (DFNWC)	72	68	61	59	48	37	36	40	32	52	52
Net Working Capital (NWC)	72	68	61	59	48	37	36	40	32	52	52
Net Nonoperating Expense (NNE)	1.22	1.40	2.28	2.39	2.10	2.91	2.66	3.46	2.97	3.19	2.60
Net Nonoperating Obligations (NNO)	-74	-70	-64	-65	-53	-46	-39	-46	-35	-55	-48
Total Depreciation and Amortization (D&A)	0.73	0.40	0.75	0.51	1.94	1.66	1.02	1.04	5.97	2.18	2.23
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-32.66%	-106.38%	-161.16%	-99.59%	-96.06%	-29.73%	-50.15%	-17.76%	-14.90%	11.31%
Debt-free Net Working Capital to Revenue	0.00%	1,548.11%	2,048.99%	1,497.68%	805.27%	409.42%	334.84%	323.73%	182.72%	213.32%	157.52%
Net Working Capital to Revenue	0.00%	1,548.11%	2,048.99%	1,497.68%	805.27%	409.42%	334.84%	323.73%	182.72%	213.32%	157.52%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.06)	($0.08)	($0.11)	($0.11)	($0.10)	($0.11)	($0.11)	($0.13)	($0.10)	($0.11)	($0.08)
Adjusted Weighted Average Basic Shares Outstanding	69.01M	71.34M	84.65M	85.22M	86.35M	86.20M	90.03M	97.05M	110.41M	101.87M	117.97M
Adjusted Diluted Earnings per Share	($0.06)	($0.08)	($0.11)	($0.11)	($0.10)	($0.11)	($0.11)	($0.13)	($0.10)	($0.11)	($0.08)
Adjusted Weighted Average Diluted Shares Outstanding	69.01M	71.34M	84.65M	85.22M	86.35M	86.20M	90.03M	97.05M	110.41M	101.87M	117.97M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	84.47M	84.63M	84.97M	86.27M	88.40M	91.60M	94.47M	111.05M	105.84M	117.93M	120.55M
Normalized Net Operating Profit after Tax (NOPAT)	-3.03	-4.65	-6.83	-7.06	-6.39	-6.82	-7.22	-9.05	-7.88	-8.23	-6.77
Normalized NOPAT Margin	-370.85%	-587.49%	-1,005.26%	-432.48%	-228.44%	-172.94%	-309.22%	-270.62%	-100.28%	-77.42%	-59.99%
Pre Tax Income Margin	-520.10%	-764.65%	-1,340.50%	-578.92%	-303.50%	-246.81%	-423.20%	-374.20%	-138.13%	-107.40%	-83.05%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-1.88%	-2.52%	-2.01%	-2.14%	-1.63%	-0.89%	-1.39%	-2.21%	-1.69%	0.00%

Key Financial Trends

Amprius Technologies (NYSE:AMPX) has continued to operate at a net loss over the past several years, reflecting its ongoing investment phase and challenges in reaching profitability. However, there are several notable trends and key financial highlights drawn from the last four years of quarterly data through Q1 2025.

Operating revenue has grown significantly from $679K in Q1 2023 to $11.28M in Q1 2025, indicating strong revenue growth and improving market demand.
Cash & equivalents increased from $64.19M in Q1 2023 to $48.42M in Q1 2025, reflecting a strong liquidity position supported by multiple equity issuances.
Issuance of common equity has been a consistent source of financing, with significant capital raises in recent quarters such as $8.46M in Q1 2025 and $22.56M in Q4 2024, strengthening the balance sheet.
Depreciation and amortization expenses remain significant but stable, around $900K-$1.3M and $1.2M respectively in recent quarters, reflecting steady investment in property, plant, and equipment.
Research and development expenses have increased moderately over time, reaching $2.00M in Q1 2025, highlighting ongoing product innovation efforts.
Operating expenses fluctuated between $6M and $9.5M across quarters, suggesting variable selling, general & administrative spending, impacting operating losses.
The company continues to report net losses each quarter, with Q1 2025 net loss at approximately $9.37M and similar losses over multiple preceding quarters, delaying profitability.
Gross profit remains negative due to costs consistently exceeding revenues, with Q1 2025 gross loss of $2.36M indicating continued margin pressure and high costs.
Net cash used in continuing operating activities increased to $14.1M in Q1 2025, suggesting higher operating cash burn despite revenue growth.
Total liabilities increased to about $48.1M in Q1 2025, up from roughly $16.9M in early 2023, mainly driven by current and noncurrent operating liabilities, which may pressure future cash flow requirements.

Summary: Amprius Technologies is in a growth and investment phase, evidenced by rapid revenue growth and substantial equity financing. However, it continues to operate at a loss with negative gross margins indicating cost challenges. The increasing operating cash burn and liabilities require attention, but strong liquidity and equity raises position it to potentially scale operations and improve financial performance over time. Investors should watch for improvement in gross margins and operating cash flows as catalysts for turning the business profitable.

08/22/25 08:41 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Amprius Technologies' Financials

When does Amprius Technologies' fiscal year end?

According to the most recent income statement we have on file, Amprius Technologies' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Amprius Technologies' net income changed over the last 3 years?

Amprius Technologies' net income appears to be on an upward trend, with a most recent value of -$44.67 million in 2024, rising from -$9.90 million in 2021. The previous period was -$36.78 million in 2023. View Amprius Technologies' forecast to see where analysts expect Amprius Technologies to go next.

What is Amprius Technologies' operating income?

Amprius Technologies' total operating income in 2024 was -$46.26 million, based on the following breakdown:

Total Gross Profit: -$18.33 million
Total Operating Expenses: $27.93 million

How has Amprius Technologies' revenue changed over the last 3 years?

Over the last 3 years, Amprius Technologies' total revenue changed from $2.77 million in 2021 to $24.17 million in 2024, a change of 771.8%.

How much debt does Amprius Technologies have?

Amprius Technologies' total liabilities were at $51.65 million at the end of 2024, a 7.8% increase from 2023, and a 1,006.3% increase since 2021.

How much cash does Amprius Technologies have?

In the past 3 years, Amprius Technologies' cash and equivalents has ranged from $11.49 million in 2021 to $69.70 million in 2022, and is currently $55.16 million as of their latest financial filing in 2024.

How has Amprius Technologies' book value per share changed over the last 3 years?

Over the last 3 years, Amprius Technologies' book value per share changed from 0.21 in 2021 to 0.66 in 2024, a change of 211.5%.

Related Companies

This page (NYSE:AMPX) was last updated on 8/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amprius Technologies (AMPX) Financials

Key Financial Trends

Frequently Asked Questions About Amprius Technologies' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Amprius Technologies (AMPX) Financials

Annual Income Statements for Amprius Technologies

Quarterly Income Statements for Amprius Technologies

Annual Cash Flow Statements for Amprius Technologies

Quarterly Cash Flow Statements for Amprius Technologies

Annual Balance Sheets for Amprius Technologies

Quarterly Balance Sheets for Amprius Technologies

Annual Metrics And Ratios for Amprius Technologies

Quarterly Metrics And Ratios for Amprius Technologies

Key Financial Trends

Frequently Asked Questions About Amprius Technologies' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools